论文部分内容阅读
尿微量白蛋白(UMALB)及尿β2-微球蛋白(Uβ2-MG)升高是原发性高血压早期肾损害的证据之一。早期有效控制血压、降低UMALB及Uβ2-MG水平是防止及逆转原发性高血压患者肾损害的关键。本文旨在探讨坎地沙坦酯与左旋氨氯地平联合治疗对原发性高血压UMALB及Uβ2-MG的影响。1资料与方
Increased urinary albumin (UMALB) and urinary β2-microglobulin (Uβ2-MG) is one of the evidences of early renal damage in patients with essential hypertension. Effective early control of blood pressure, reduce UMALB and Uβ2-MG levels in patients with essential hypertension to prevent and reverse the key to renal damage. This article aims to investigate the effects of candesartan cilexetil and levamlodipine on the patients with essential hypertension and Uβ2-MG. 1 data and party